Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kayne Anderson BDC is a publicly traded business development company that provides private credit to U.S. middle-market companies. The company is externally managed by KA Credit Advisors, an indirect controlled subsidiary of Kayne Anderson, and focuses primarily on first lien senior secured loans, with a secondary focus on unitranche and split-lien loans. Its investment objective is to generate current income and, to a lesser extent, capital appreciation. Kayne Anderson BDC is not a biotech, pharma, or healthcare operating company; it is a specialty finance and investment vehicle within Kayne Anderson’s private credit platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kayne Anderson BDC.